Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Cepharanthine could be a strong antiviral against COVID-19.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Indinavir and ritonavir therapy can cause reversible hair loss.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

34% of patients on hepatitis C treatment had reversible skin issues.